NES
NVS icon

New England Securities’s Novartis NVS Stock Holding History

New England Securities’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$135K Sell
1,632
-67
-4% -$5.55K 0.05% 354
2014
Q3 		$143K Buy
1,699
+173
+11% +$14K 0.05% 349
2014
Q2 		$124K Sell
1,526
-25
-2% -$1.97K 0.04% 392
2014
Q1 		$118K Sell
1,551
-446
-22% -$32.5K 0.05% 362
2013
Q4 		$144K Sell
1,997
-257
-11% -$17.9K 0.06% 324
2013
Q3 		$155K Buy
2,254
+1,107
+97% +$73.2K 0.08% 264
2013
Q2 		$73K Buy
+1,147
New +$74.6K 0.05% 349

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

New England Securities's NVS Position: Q4 2014 in Review

New England Securities reduced its Novartis (NVS) stake by 3.9% in Q4 2014, selling an estimated $5.55K and leaving 1,632 shares worth $135K. The position accounts for 0.05% of the portfolio, ranked #354.

New England Securities first reported a position in NVS in Q2 2013 and has held it in 7 quarters since. The position peaked at $155K in Q3 2013. 918 funds tracked by Wall St. Rank hold NVS as of Q4 2014.

  • New England Securities held 1,632 shares of Novartis worth $135K as of Q4 2014.
  • New England Securities sold 67 Novartis shares in Q4 2014, an estimated $5.55K.
  • Novartis made up 0.05% of New England Securities's portfolio in Q4 2014, its #354 holding.
  • New England Securities first reported a position in Novartis in Q2 2013 and has held it in 7 quarters since.
  • New England Securities's Novartis position peaked at $155K in Q3 2013.
  • 918 funds tracked by Wall St. Rank held Novartis as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.